Differentiating between IPF and NSIP

Chronic Respiratory Disease

Volumn 7, Issue 3, 2010, Pages 187-195

  Glaspole, Ian ^a   Goh, Nicole Soo Leng ^b  

^a ALFRED HOSPITAL   (Australia)

^b AUSTIN HOSPITAL   (Australia)

Author keywords

HRCT chest; multidisciplinary approach; prognosis; surgical lung biopsy

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; PIRFENIDONE; PREDNISOLONE;

ABNORMAL RESPIRATORY SOUND; AGE; BRONCHIECTASIS; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLUBBING FINGERS; COUGHING; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE COURSE; DYSPNEA; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; NONSPECIFIC INTERSTITIAL PNEUMONIA; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY REHABILITATION; RADIODIAGNOSIS; REVIEW; SEX DIFFERENCE; SURVIVAL; TEAMWORK;

BIOPSY; CLINICAL TRIALS AS TOPIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; LUNG DISEASES, INTERSTITIAL; PATIENT CARE TEAM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77955894408     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972310376205     Document Type: Review

References (56)

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This Joint Statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS Board of Directors, June 2001, and by The ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002 ; 165: 277-304.
2. Myers JL, Katzenstein AL Beyond a consensus classification for idiopathic interstitial pneumonias: progress and controversies. Histopathology 2009 ; 54: 90-103.
3. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000 ; 161: 646-664.
4. King TE Jr, Tooze JA, Schwarz MI, Brown KR, and Cherniack RM Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001 ; 164: 1171-1181.
5. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998 ; 157: 199-203.
6. Daniil ZD, Gilchrist FC, Nicholson AG, Hansell DM, Harris J., Colby TV, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999 ; 160: 899-905.
7. Katzenstein AL, Fiorelli RF Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994 ; 18: 136-147.
8. Nicholson AG, Colby TV, du Bois RM, Hansell DM, and Wells AU The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000 ; 162: 2213-2217.
9. Travis WD, Matsui K., Moss J., and Ferrans VJ Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000 ; 24: 19-33.
10. Flaherty KR, Toews GB, Travis WD, Colby TV, Kazerooni EA, Gross BH, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002 ; 19: 275-283.
11. Travis WD, Hunninghake G., King TE Jr, Lynch DA, Colby TV, Galvin JR, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008 ; 177: 1338-1347.
12. Park JH, Kim DS, Park IN, Jang SJ, Kitaichi M., Nicholson AG, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007 ; 175: 705-711.
13. Cottin V., Donsbeck AV, Revel D., Loire R., and Cordier JF Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998 ; 158: 1286-1293.
14. Kinder BW, Collard HR, Koth L., Daikh DI, Wolters PJ, Elicker B., et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 2007 ; 176: 691-697.
15. Johnston ID, Prescott RJ, Chalmers JC, and Rudd RM British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. Thorax 1997 ; 52: 38-44.
16. Grenier P., Chevret S., Beigelman C., Brauner MW, Chastang C., and Valeyre D. Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis. Radiology 1994 ; 191: 383-390.
17. Grenier P., Valeyre D., Cluzel P., Brauner MW, Lenoir S., and Chastang C. Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high-resolution CT. Radiology 1991 ; 179: 123-132.
18. Mayo JR, Webb WR, Gould R., Stein MG, Bass I., Gamsu G., et al. High-resolution CT of the lungs: an optimal approach. Radiology 1987 ; 163: 507-510.
19. Sumikawa H., Johkoh T., Ichikado K., Taniguchi H., Kondoh Y., Fujimoto K., et al. Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia: analysis of CT appearance in 92 patients. Radiology 2006 ; 241: 258-266.
20. Lynch DA, Travis WD, Muller NL, Galvin JR, Hansell DM, Grenier PA, et al. Idiopathic interstitial pneumonias: CT features. Radiology 2005 ; 236: 10-21.
21. Mathieson JR, Mayo JR, Staples CA, and Muller NL Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989 ; 171: 111-116.
22. Tung KT, Wells AU, Rubens MB, Kirk JM, du Bois RM, and Hansell DM Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. Thorax 1993 ; 48: 334-338.
23. Swensen SJ, Aughenbaugh GL, and Myers JL Diffuse lung disease: diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung. Radiology 1997 ; 205: 229-234.
24. Hunninghake GW, Zimmerman MB, Schwartz DA, King TE Jr, Lynch J., Hegele R., et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001 ; 164: 193-196.
25. Lynch DA, David GJ, Safrin S., Starko KM, Hormel P., Brown KK, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005 ; 172: 488-493.
26. Flaherty KR, Andrei AC, King TE Jr, Raghu G., Colby TV, Wells A., et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med 2007 ; 175: 1054-1060.
27. Aziz ZA, Wells AU, Hansell DM, Bain GA, Copley SJ, Desai SR, et al. HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax 2004 ; 59: 506-511.
28. Bradley B., Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008 ; 63: v1 - v58.
29. Johkoh T., Muller NL, Cartier Y., Kavanagh PV, Hartman TE, Akira M., et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999 ; 211: 555-560.
30. Elliot TL, Lynch DA, Newell JD Jr, Cool C., Tuder R., Markopoulou K., et al. High-resolution computed tomography features of nonspecific interstitial pneumonia and usual interstitial pneumonia. J Comput Assist Tomogr 2005 ; 29: 339-345.
31. MacDonald SL, Rubens MB, Hansell DM, Copley SJ, Desai SR, du Bois RM, et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001 ; 221: 600-605.
32. Flaherty KR, Thwaite EL, Kazerooni EA, Gross BH, Toews GB, Colby TV, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003 ; 58: 143-148.
33. Mogulkoc N., Brutsche MH, Bishop PW, Greaves SM, Horrocks AW, and Egan JJ Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 2001 ; 164: 103-108.
34. Goh NS, Desai SR, Veeraraghavan S., Hansell DM, Copley SJ, Maher TM, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008 ; 177: 1248-1254.
35. Silva CI, Muller NL, Hansell DM, Lee KS, Nicholson AG, and Wells AU Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology 2008 ; 247: 251-259.
36. Katzenstein AL, Mukhopadhyay S., and Myers JL Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum Pathol 2008 ; 39: 1275-1294.
37. Nicholson AG, Fulford LG, Colby TV, du Bois RM, Hansell DM, and Wells AU The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002 ; 166: 173-177.
38. King TE Jr, Schwarz MI, Brown K., Tooze JA, Colby TV, Waldron JA Jr, et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001 ; 164: 1025-1032.
39. Katzenstein AL, Zisman DA, Litzky LA, Nguyen BT, and Kotloff RM Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol 2002 ; 26: 1567-1577.
40. Flaherty KR, Travis WD, Colby TV, Toews GB, Kazerooni EA, Gross BH, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001 ; 164: 1722-1727.
41. Monaghan H., Wells AU, Colby TV, du Bois RM, Hansell DM, and Nicholson AG Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004 ; 125: 522-526.
42. Nicholson AG, Addis BJ, Bharucha H., Clelland CA, Corrin B., Gibbs AR, et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax 2004 ; 59: 500-505.
43. Bouros D., Wells AU, Nicholson AG, Colby TV, Polychronopoulos V., Pantelidis P., et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002 ; 165: 1581-1586.
44. Yoshinouchi T., Ohtsuki Y., Fujita J., Yamadori I., Bandoh S., Ishida T., et al. Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int 2005 ; 26: 121-125.
45. Flaherty KR, King TE Jr, Raghu G., Lynch JP 3rd, Colby TV, Travis WD, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004 ; 170: 904-910.
46. Thomeer M., Demedts M., Behr J., Buhl R., Costabel U., Flower CD, et al. Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur Respir J 2008 ; 31: 585-591.
47. Latsi PI, du Bois RM, Nicholson AG, Colby TV, Bisirtzoglou D., Nikolakopoulou A., et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003 ; 168: 531-537.
48. Flaherty KR, Mumford JA, Murray S., Kazerooni EA, Gross BH, Colby TV, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003 ; 168: 543-548. (Pubitemid 37088596)
49. Noble P., Albera C., Bradford W., Costabel U., Kardatzke D., King TJ, et al. The CAPACITY (CAP) trials: randomized, double-blind, placebo-controlled, phase III trials of Pirfenidone (PFD) in patients with Idiopathic Pulmonary Fibrosis (IPF). Am J Respir Crit Care Med 2009 ; 179 [ A1129 ]. Ref Type: Abstract.
50. Taniguchi H., Ebina M., Kondoh Y., Ogura T., Azuma A., Suga M., et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 2010 ; 35: 821-829.
51. Hoyles RK, Ellis RW, Wellsbury J., Lees B., Newlands P., Goh NS, et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 2006 ; 54: 3962-3970.
52. Tashkin DP, Elashoff R., Clements PJ, Goldin J., Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006 ; 354: 2655-2666.
53. Holland AE, Hill CJ, Conron M., Munro P., and McDonald CF Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008 ; 63: 549-554.
54. Holland A., Hill C. Physical training for interstitial lung disease. Cochrane Database Syst Rev 2008 ; (4). CD006322.
55. Nishiyama O., Kondoh Y., Kimura T., Kato K., Kataoka K., Ogawa T., et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2008 ; 13: 394-399.
56. Swigris JJ, Brown KK, Make BJ, and Wamboldt FS Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med 2008 ; 102: 1675-1680.